Protein folding revisited. A polypeptide chain at the folding - Misfolding - Nonfolding cross-roads: Which way to go?

Cellular and Molecular Life Sciences

Volumn 60, Issue 9, 2003, Pages 1852-1871

  Uversky, V N ^a,b  

^a INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intrinsically disordered protein; Misfolding; Natively unfolded protein; Nonfolding; Partially folded intermediate; Protein folding; Random coil; Unfolded protein

Indexed keywords

AMINO ACID; GLOBULAR PROTEIN; PROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; LEWY BODY; MOLECULAR MECHANICS; PANCREAS ISLET BETA CELL; PH MEASUREMENT; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; HUMANS; NERVE TISSUE PROTEINS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; SYNUCLEINS; THERMODYNAMICS;

EID: 0141861067     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3096-6     Document Type: Review

References (209)

1. Bryngelson J. D., Onuchic J. N., Socci N. D. and Wolynes P. G. (1995) Funnels, pathways and the energy landscape of protein folding - a synthesis. Proteins Structure Function Genetics 21: 167-195
2. Dill K. A. and Chan H. S. (1997) From Levinthal to pathways to funnels. Nat. Struct. Biol. 4: 10-19
3. Dobson C. M., Sali A. and Karplus M. (1998) Protein folding: a perspective from theory and experiment. Angew. Chem. Int. Ed. 37: 868-893
4. Dobson C. M. and Karplus M. (1999) The fundamentals of protein folding: bringing together theory and experiment. Curr. Opin. Struct. Biol. 9: 92-101
5. Dinner A. R., Sali A., Smith L. J., Dobson C. M. and Karplus M. (2000) Understanding protein folding via free-energy surfaces from theory and experiment. Trends Biochem. Sci. 25: 331-339
6. Fersht A. R. and Daggett V. (2002) Protein folding and unfolding at atomic resolution. Cell 108: 573-582
7. Ptitsyn O. B. and Volkenstein M. V. (1986) Protein structure and neutral theory of evolution. J. Biomol. Struct. Dynamics 4: 137-156
8. Lau K. F. and Dill K. A. (1990) Theory for protein mutability and biogenesis. Proc. Natl. Acad. Sci. USA 87: 638-642
9. Ptitsyn O. B. (1995) Molten globule and protein folding. Adv. Protein Chem. 47: 83-229
10. Tcherkasskaya O. and Uversky V. N. (2001) Denatured collapsed states in protein folding: Example of apomyoglobin. Proteins Structure Function Genetics 44: 244-254
11. Uversky V. N. (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 11: 739-756
12. Uversky V. N. (2002) What does it mean to be natively unfolded? Eur. J. Biochem. 269: 2-12
13. Tcherkasskaya O., Davidson E. A. and Uversky V. N. (2003) Biophysical constraints for protein structure prediction. J. Proteome Res. 2: 37-42
14. Grossberg A.Yu. and Khohlov A. R. (1989) Statistical Physics of Macromolecules, Nauka, Moscow
15. Baldwin R. L. (1986) Seeding protein folding. Trends Biochem. Sci. 11: 6-9
16. Finkelstein A. V., Galzitskaya O. V. and Badretdinov A. Y. (1996) A folding pathway solving Levinthal's paradox. Progr. Biophys. Mol. Biol. 65: A412
17. Tanford C. (1968) Protein denaturation. Adv. Protein Chem. 23: 121-282
18. Tanford C. (1961) Physical Chemistry of Macromolecules, Wiley, New York
19. Smith L. J., Fiebig K. M., Schwalbe H. and Dobson C. M. (1996) The concept of a random coil - residual structure in peptides and denatured proteins. Folding Design 1: R95-R106
20. Miller W. G. and Goebel C. V. (1968) Dimensions of protein random coils. Biochemistry 7: 3925-3935
21. Alexandrescu A. T., Abeygunawardana C. and Shortle D. (1994) Structure and dynamics of a denatured 131-residue fragment of staphylococcal nuclease: a heteronuclear NMR study. Biochemistry 33: 1063-1072
22. Wang Y. and Shortle D. (1995) The equilibrium folding pathway of staphylococcal nuclease: identification of the most stable chain-chain interactions by NMR and CD spectroscopy. Biochemistry 34: 15895-15905
23. Wang Y. and Shortle D. (1997) Residual helical and turn structure in the denatured state of staphylococcal nuclease: analysis of peptide fragments. Folding Design 2: 93-100
24. Wang Y. and Shortle D. (1996) A dynamic bundle of four adjacent hydrophobic segments in the denatured state of staphylococcal nuclease. Protein Sci. 5: 1898-1906
25. Gillespie J. R. and Shortle D. (1997) Characterization of long-range structure in the denatured state of staphylococcal nuclease. II. Distance restraints from paramagnetic relaxation and calculation of an ensemble of structures. J. Mol. Biol. 268: 170-184
26. Shortle D. and Ackerman M. S. (2001) Persistence of native-like topology in a denatured protein in 8 M urea. Science 293: 487-489
27. James E., Wu P. G., Stites W. and Brand L. (1992) Compact denatured state of a staphylococcal nuclease mutant by guanidinium as determined by resonance energy-transfer. Biochemistry 31: 10217-10225
28. Saab-Rincon G., Froebe C. L. and Matthews C. R. (1993) Urea-induced unfolding of the alpha subunit of tryptophan synthase: one-dimensional proton NMR evidence for residual structure near histidine-92 at high denaturant concentration. Biochemistry 32: 13981-13990
29. Saab-Rincon G., Gualfetti P. J. and Matthews C. R. (1996) Mutagenic and thermodynamic analyses of residual structure in the alpha subunit of tryptophan synthase. Biochemistry 35: 1988-1994
30. Neri D., Billeter M., Wider G. and Wuthrich K. (1992) NMR determination of residual structure in a urea-denatured protein, the 434-repressor. Science 257: 1559-1563
31. Zhang O. and Forman-Kay J. D. (1995) Structural characterization of folded and unfolded states of an SH3 domain in equilibrium in aqueous buffer. Biochemistry 34: 6784-6794
32. Zhang O. and Forman-Kay J. D. (1997) NMR studies of unfolded states of an SH3 domain in aqueous solution and denaturing conditions. Biochemistry 36: 3959-3970
33. Schulman B. A., Kim P. S., Dobson C. M. and Redfield C. (1997) A residue-specific NMR view of the non-cooperative unfolding of a molten globule. Nat. Struct. Biol. 4: 630-634
34. Nolting B., Golbik R., Solergonzalez A. S. and Fersht A. R. (1997) Circular dichroism of denatured barstar suggests residual structure. Biochemistry 36: 9899-9905
35. Koepf E. K., Petrassi H. M., Sudol M. and Kelly J. W. (1999) WW: an isolated three-stranded antiparallel beta-sheet domain that unfolds and refolds reversibly; evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered thermal unfolded state. Protein Sci. 8: 841-853
36. Gottfried D. S. and Haas E. (1992) Nonlocal interactions stabilize compact folding intermediates in reduced unfolded bovine pancreatic trypsin inhibitor. Biochemistry 31: 12353-12362
37. Amir D., Krausz S. and Haas E. (1992) Detection of local structures in reduced unfolded bovine pancreatic trypsin inhibitor. Proteins 13: 162-173
38. Svensson M., Jonasson P., Freskgard P. O., Jonsson B. H., Lindgren M., Martensson L. G. et al. (1995) Mapping the folding intermediate of human carbonic anhydrase II. Probing substructure by chemical reactivity and spin and fluorescence labeling of engineered cysteine residues. Biochemistry 34: 8606-8620
39. Martensson L. G., Jonsson B. H., Freskgard P. O., Kihlgren A., Svensson M. and Carlsson U. (1993) Characterization of folding intermediates of human carbonic anhydrase II: probing substructure by chemical labeling of SH groups introduced by site-directed mutagenesis. Biochemistry 32: 224-231
40. Hammarstrom P. and Carlsson U. (2000) Is the unfolded state the Rosetta Stone of the protein folding problem? Biochem. Biophys. Res Commun. 276: 393-398
41. Schwarzinger S., Wright P. E. and Dyson H. J. (2002) Molecular hinges in protein folding: the urea-denatured state of apomyoglobin. Biochemistry 41: 12681-12686
42. Klein-Seetharaman J., Oikawa M., Grimshaw S. B., Wirmer J., Duchardt E., Ueda T. et al. (2002) Long-range interactions within a nonnative protein. Science 295: 1719-1722
43. Shortle (1996) Structural analysis of non-native states of proteins by nmr methods. Curr. Opin. Struct. Biol. 6: 24-30
44. Shortle D. (1996) The denatured state (the other half of the folding equation) and its role in protein stability. FASEB J. 10: 27-34
45. Dill K. A. and Shortle D. (1991) Denatured states of proteins. Annu. Rev. Biochem. 60: 795-825
46. Baldwin R. L. and Zimm B. H. (2000) Are denatured proteins ever random coils? Proc. Natl. Acad. Sci. USA 97: 12391-12392
47. Plaxco K. W. and Gross M. (2001) Unfolded, yes, but random? Never! Nat. Struct. Biol. 8: 659-660
48. Ramachandran G. N. and Sasisekharan V. (1968) Conformation of polypeptides and proteins. Adv. Protein Chem. 23: 283-438
49. Shortle D. (2002) The expanded denatured state: an ensemble of conformations trapped in a locally encoded topological space. Adv. Protein Chem. 62: 1-23
50. Shimizu S. and Chan H. S. (2002) Origins of protein denatured state compactness and hydrophobic clustering in aqueous urea: inferences from nonpolar potentials of mean force. Proteins 49: 560-566
51. Palleros D. R., Shi L., Reid K. L. and Fink A. L. (1993) Three-state denaturation of DnaK induced by guanidine hydrochloride. Evidence for an expandable intermediate. Biochemistry 32: 4314-4321
52. Uversky V. N. and Ptitsyn O. B. (1994) 'Partly folded' state, a new equilibrium state of protein molecules: four-state guanidinium chloride-induced unfolding of beta-lactamase at low temperature. Biochemistry 33: 2782-2791
53. Ptitsyn O. B., Bychkova V. E. and Uversky V. N. (1995) Kinetic and equilibrium folding intermediates. Phil. Trans. Roy. Soc. London B 348: 35-41
54. Uversky V. N. and Ptitsyn O. B. (1996) Further evidence on the equilibrium 'pre-molten globule state': four-state guanidinium chloride-induced unfolding of carbonic anhydrase B at low temperature. J. Mol. Biol. 255: 215-228
55. Zhang Y. L., Zhou J. M. and Tsou C. L. (1996) Sequential unfolding of adenylate kinase during denaturation by guanidine hydrochloride. Biochim. Biophys. Acta 1295: 239-244
56. Uversky V. N. (1997) Diversity of equilibrium compact forms of denatured globular proteins. Protein Peptide Lett. 4: 355-367
57. Karnoup A. S. and Uversky V. N. (1997) Sequential compaction of a random copolymer of hydrophilic and hydrophobic amino acid residues. Macromolecules 30: 7427-7434
58. Uversky V. N., Karnoup A. S., Segel D. J., Seshadri S., Doniach S. and Fink A. L. (1998) Anion-induced folding of staphylococcal nuclease: characterization of multiple equilibrium partially folded intermediates. J. Mol. Biol. 278: 879-894
59. Bushmarina N. A., Kuznetsova I. M., Biktashev A. G., Turoverov K. K. and Uversky V. N. (2001) Partially folded conformations in the folding pathway of bovine carbonic anhydrase II: A fluorescence spectroscopic analysis. Chembiochem 2: 813-821
60. Kuznetsova I. M., Stepanenko O. V., Turoverov K. K., Zhu L., Zhou J. M., Fink A. L. et al. (2002) Unraveling multistate unfolding of rabbit muscle creatine kinase. Biochim. Biophys. Acta protein Struct. Mol. Enzymol. 1596: 138-155
61. Mirsky A. E. and Pauling L. (1937) On the structure of native, denatured and coagulated proteins. Proc. Natl. Acad. Sci. USA 33: 439-441
62. Karplus M. and Weaver D. L. (1976) Protein-folding dynamics. Nature 260: 404-406
63. Kim P. S. and Baldwin R. L. (1982) Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding. Annu. Rev. Biochem. 51: 459-489
64. Kauzmann W. (1959) Some factors in the interpretation of protein denaturation. Adv. Protein Chem. 14: 1-63
65. Dill K. A. (1985) Theory for the folding and stability of globular proteins. Biochemistry 24: 1501-1509
66. Covell D. G. and Jernigan R. L. (1990) Conformations of folded proteins in restricted spaces. Biochemistry 29: 3287-3294
67. Chan H. S. and Dill K. A. (1990) Origins of structure in globular proteins. Proc. Natl. Acad. Sci. USA 87: 6388-6392
68. Gregoret L. M. and Cohen F. E. (1991) Protein folding. Effect of packing density on chain conformation. J. Mol. Biol. 219: 109-122
69. Fink A. L. (1995) Compact intermediate states in protein folding. Annu. Rev. Biophys. Biomol. Struct. 24: 495-522
70. Uversky V. N. and Fink A. L. (2002) The chicken-egg scenario of protein folding revisited. FEBS Lett. 515: 79-83
71. Evans P. A., Topping K. D., Woolfson D. N. and Dobson C. M. (1991) Hydrophobic clustering in nonnative states of a protein: interpretation of chemical shifts in NMR spectra of denatured states of lysozyme. Proteins 9: 248-266
72. Logan T. M., Theriault Y. and Fesik S. W. (1994) Structural characterization of the FK506 binding protein unfolded in urea and guanidine hydrochloride. J. Mol. Biol. 236: 637-648
73. Lumb K. J. and Kim P. S. (1994) Formation of a hydrophobic cluster in denatured bovine pancreatic trypsin inhibitor. J. Mol. Biol. 236: 412-420
74. Arcus V. L., Vuilleumier S., Freund S. M., Bycroft M. and Fersht A. R. (1995) A comparison of the Ph, urea and temperature-denatured states of barnase by heteronuclear NMR: implications for the initiation of protein folding. J. Mol. Biol. 254: 305-321
75. Miranker A. D. and Dobson C. M. (1996) Collapse and cooperativity in protein folding. Curr. Opin. Struct. Biol. 6: 31-42
76. Wong K. B., Freund S. M. and Fersht A. R. (1996) Cold denaturation of barstar: 1h, 15n and 13c nmr assignment and characterisation of residual structure. J. Mol. Biol. 259: 805-818
77. Schwalbe H., Fiebig K. M., Buck M., Jones J. A., Grimshaw S. B., Spencer A. et al. (1997) Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M urea. Biochemistry 36: 8977-8991
78. Blanco F. J., Serrano L. and Forman-Kay J. D. (1998) High populations of non-native structures in the denatured state are compatible with the formation of the native folded state. J. Mol. Biol. 284: 1153-1164
79. Kortemme T., Kelly M. J., Kay L. E., Forman-Kay J. and Serrano L. (2000) Similarities between the spectrin SH3 domain denatured state and its folding transition state. J. Mol. Biol. 297: 1217-1229
80. Garcia P., Serrano L., Durand D., Rico M. and Bruix M. (2001) NMR and SAXS characterization of the denatured state of the chemotactic protein CheY: implications for protein folding initiation. Protein Sci. 10: 1100-1112
81. Flory P. J. (1953) Principles of Polymer Chemistry, Cornell University Press, Ithaca, NY
82. Fernandez A., Kardos J. and Goto Y. (2003) Protein folding: could hydrophobic collapse be coupled with hydrogen-bond formation? FEBS Lett. 536: 187-192
83. Anfinsen C. B., Haber E., Sela M. and White F. N. (1961) The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proc. Natl. Acad. Sci. USA 47: 1309-1314
84. Kuwajima K. (1996) The molten globule state of alpha-lactalbumin. FASEB J. 10: 102-109
85. Uversky V. N. (2002) Cracking the folding code. Why do some proteins adopt partially folded conformations, whereas other don't? FEBS Lett. 514: 181-183
86. Kelly J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8: 101-106
87. Dobson C. M. (1999) Protein misfolding, evolution and disease. Trends Biochem. Sci. 24: 329-332
88. Bellotti V., Mangione P. and Stoppini M. (1999) Biological activity and pathological implications of misfolded proteins. Cell. Mol. Life Sci. 55: 977-991
89. Uversky V. N., Talapatra A., Gillespie J. R. and Fink A. L. (1999) Protein deposits as the molecular basis of amyloidosis. Part I. Systemic amyloidoses. Med. Sci. Monitor 5: 1001-1012
90. Uversky V. N., Talapatra A., Gillespie J. R. and Fink A. L. (1999) Protein deposits as the molecular basis of amyloidosis. II. Localized amyloidosis and neurodegenerative disorders. Med. Sci. Monitor 5: 1238-1254
91. Rochet J. C. and Lansbury P. T. Jr (2000) Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10: 60-68
92. Sunde M., Serpell L. C., Bartlam M., Fraser P. E., Pepys M. B. and Blake C. C. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273: 729-739
93. Goldsbury C. S., Cooper G. J. S., Goldie K. N., Muller S. A., Saafi E. L., Gruijters W. T. M. et al. (1997) Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119: 17-27
94. Harper J. D., Lieber C. M. and Lansbury P. T. Jr (1997) Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 4: 951-959
95. Conway K. A., Harper J. D. and Lansbury P. T. Jr (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson's disease. Nat. Med. 4: 1318-1320
96. Serpell L. C., Sunde M., Benson M. D., Tennent G. A., Pepys M. B. and Fraser P. E. (2000) The protofilament substructure of amyloid fibrils. J. Mol. Biol. 300: 1033-1039
97. Uversky V. N., Li J. and Fink A. L. (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276: 10737-10744
98. Guijarro J. I., Sunde M., Jones J. A., Campbell I. D. and Dobson C. M. (1998) Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 95: 4224-4228
99. Litvinovich S. V., Brew S. A., Aota S., Akiyama S. K., Haudenschild C. and Ingham K. C. (1998) Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 280: 245-258
100. Konno T., Murata K. and Nagayama K. (1999) Amyloid-like aggregates of a plant protein: a case of a sweet-tasting protein, monellin. FEBS Lett. 454: 122-126
101. Schuler B., Rachel R. and Seckler R. (1999) Formation of fibrous aggregates from a non-native intermediate: the isolated P22 tailspike beta-helix domain. J. Biol. Chem. 274: 18589-18596
102. Gross M., Wilkins D. K., Pitkeathly M. C., Chung E. W., Higham C., Clark A. et al. (1999) Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci. 8: 1350-1357
103. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Pamponi G. et al. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA 96: 3590-3594
104. Krebs M. R., Wilkins D. K., Chung E. W., Pitkeathly M. C., Chamberlain A. K., Zurdo J. et al. (2000) Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 300: 541-549
105. Damaschun G., Damaschun H., Fabian H., Gast K., Krober R., Wieske M. et al. (2000) Conversion of yeast phosphoglycerate kinase into amyloid-like structure. Proteins 39: 204-211
106. Yutani K., Takayama G., Goda S., Yamagata Y., Maki S., Namba K. et al. (2000) The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus. Biochemistry 39: 2769-2777
107. Ohnishi S., Koide A. and Koide S. (2000) Solution conformation and amylold-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. J. Mol. Biol. 301: 477-489
108. Fezoui Y., Hartley D. M., Walsh D. M., Selkoe D. J., Osterhout J. J. and Teplow D. B. (2000) A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat. Struct. Biol. 7: 1095-1099
109. Fandrich M., Fletcher M. A. and Dobson C. M. (2001) Amyloid fibrils from muscle myoglobin. Nature 410: 165-166
110. Pertinhez T. A., Bouchard M., Tomlinson E. J., Wain R., Ferguson S. J., Dobson C. M. et al. (2001) Amyloid fibril formation by a helical cytochrome. FEBS Lett. 495: 184-186
111. Nielsen L., Frokjaer S., Brange J., Uversky V. N. and Fink A. L. (2001) Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40: 8397-8409
112. Johansson J. (2001) Membrane properties and amyloid fibril formation of lung surfactant protein C. Biochem. Soc. Trans. 29: 601-606
113. Souillac P. O., Uversky V. N., Millett I. S., Khurana R., Doniach S. and Fink A. L. (2002) Effect of association state and conformational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH. J. Biol. Chem. 277: 12657-12665
114. Pavlov N. A., Cherny D. I., Helm G., Jovin T. M. and Subramaniam V. (2002) Amyloid fibrils from the mammalian protein prothymosin alpha. FEBS Lett. 517: 37-40
115. Goers J., Permyakov S. E., Permyakov E. A., Uversky V. N. and Fink A. L. (2002) Conformational prerequisites for alpha-lactalbumin fibrillation. Biochemistry 41: 12546-12551
116. Lansbury P. T. Jr (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. USA 96: 3342-3344
117. Fink A. L. (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Folding Design 3: 9-15
118. Dobson C. M. (2001) Protein folding and its links with human disease. Biochem. Soc. Symp. 68: 1-26
119. Zerovnik E. (2002) Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem. 269: 3362-3371
120. Teplow D. B. (1998) Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid Int. J. Exp. Clin. Invest. 5: 121-142
121. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W. et al. (1999) Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287: 781-796
122. Schweers O., Schonbrunn-Hanebeck E., Marx A. and Mandelkow E. (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J. Biol. Chem. 269: 24290-24297
123. Kelly J. W. (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6: 11-17
124. Wetzel R. (1997) Domain stability in immunoglobulin light chain deposition disorders. Adv. Protein Chem. 50: 183-242
125. Wetzel R. (1999) Amyloid, Prions and Other Protein Aggregates, Academic Press, San Diego
126. Canet D., Sunde M., Last A. M., Miranker A., Spencer A., Robinson C. V. et al. (1999) Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. Biochemistry 38: 6419-6427
127. Lashuel H. A., Wurth C., Woo L. and Kelly J. W. (1999) The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. Biochemistry 38: 13560-13573
128. Saraiva M. J. (2001) Transthyretin amyloidosis: a tale of weak interactions. FEBS Lett. 498: 201-203
129. Heegaard N. H., Sen J. W., Kaarsholm N. C. and Nissen M. H. (2001) Conformational intermediate of the amyloidogenic protein beta 2-microglobulin at neutral pH. J. Biol. Chem. 276: 32657-32662
130. Colon W., Lai Z., McCutchen S. L., Miroy G. J., Strang C. and Kelly J. W. (1996) FAP mutations destabilize transthyretin facilitating conformational changes required for amyloid formation. Ciba Found. Symp. 199: 228-238
131. Chiti F., Taddei N., Stefani M., Dobson C. M. and Ramponi G. (2001) Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation. Protein Sci. 10: 879-886
132. Miroy G. J., Lai Z., Lashuel H. A., Peterson S. A., Strang C. and Kelly J. W. (1996) Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl. Acad. Sci. USA 93: 15051-15056
133. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S. et al. (2001) Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry 40: 6036-6046
134. Saraiva M. J., Birken S., Costa P. P. and Goodman D. S. (1984) Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest 74: 104-119
135. Lai Z., Colón W and Kelly J. W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 6470-6482
136. Jiang X., Smith C. S., Petrassi H. M., Hammarstrom P., White J. T., Sacchettini J. C. et al. (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40: 11442-11452
137. Buxbaum J. (1992) Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol. Oncol. Clin. North Am 6: 323-346
138. Khurana R., Gillespie J. R., Talapatra A., Minert L. J., Ionescu-Zanetti C., Millett I. et al. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40: 3525-3535
139. Souillac P. O., Uversky V. N., Millett I. S., Khurana R., Doniach S. and Fink A. L. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation - evidence for an off-pathway oligomer at acidic pH. J. Biol. Chem. 277: 12666-12679
140. Permyakov E. A. and Berliner L. J. (2000) alpha-Lactalbumin: structure and function. FEBS Lett. 473: 269-274
141. Hamada D. and Dobson C. M. (2002) A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. Protein Sci 11: 2417-2426
142. Ramirez-Alvarado M., Merkel J. S. and Regan L. (2000) A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. USA 97: 8979-8984
143. Uversky V. N., Li J. and Fink A. L. (2001) Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett. 500: 105-108
144. Manning-Bog A. B., McCormack A. L., Li J., Uversky V. N., Fink A. L. and Di Monte D. A. (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice - paraquat and alpha-synuclein. J. Biol. Chem. 277: 1641-1644
145. Uversky V. N., Li J. and Fink A. L. (2001) Metal-triggered structural transformations, aggregation and fibrillation of human alpha-synuclein - a possible molecular link between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276: 44284-44296
146. Uversky V. N., Li J. and Fink A. L. (2001) Trimethylamine-N-oxide-induced folding of alpha-synuclein. FEBS Lett. 509: 31-35
147. Munishkina L. A., Phelan C., Uversky V. N. and Fink A. L. (2003) Conformational behavior and aggregation of human α-synuclein in organic solvents. Modeling the effect of membranes. Biochemistry 42: 2720-2730
148. Uversky V. N., Yamin G., Souillac P. O., Goers J., Glaser C. B. and Fink A. L. (2002) Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett. 517: 239-244
149. Cooper G. J., Willis A. C., Clark A., Turner R. C., Sim R. B. and Reid K. B. (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84: 8628-8632
150. Zagorski M. G., Yang J., Shao H., Ma K., Zeng H. and Hong A. (1999) Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods Enzymol. 309: 189-204
151. Kirkitadze M. D., Condron M. M. and Teplow D. B. (2001) Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 312: 1103-1119
152. Gast K., Damaschun H., Eckert K., Schulze-Forster K., Manrer H. R., Muller-Frohne M. et al. (1995) Prothymosin alpha: a biologically active protein with random coil conformation. Biochemistry 34: 13211-13218
153. Uversky V. N., Gillespie J. R., Millett I. S., Khodyakova A. V., Vasiliev A. M., Chernovskaya T. V. et al. (1999) Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH. Biochemistry 38: 15009-15016
154. Vassilenko K. S. and Uversky V. N. (2002) Native-like secondary structure of molten globules. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1594: 168-177
155. Morozova-Roche L. A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D. B. et al. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130: 339-351
156. Nandi P. K., Leclerc E., Nicole J. C. and Takahashi M. (2002) DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. J. Mol. Biol. 322: 153-161
157. Weinreb P. H., Zhen W., Poon A. W., Conway K. A. and Lansbury P. T. Jr (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35: 13709-13715
158. Wright P. E. and Dyson H. J. (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293: 321-331
159. Dunker A. K., Lawson J. D., Brown C. J., Williams R. M., Romero P., Oh J. S. et al. (2001) Intrinsically disordered protein. J. Mol. Graphics Modelling 19: 26-59
160. Uversky V. N., Gillespie J. R. and Fink A. L. (2000) Why are 'natively unfolded' proteins unstructured under physiologic conditions? Proteins Struct. Function Genetics 41: 415-427
161. Fischer E. (1894) Einfluss der configuration auf die wirkung der enzyme. Ber. Dt. Chem. Ges. 27: 2993
162. Clayton D. F. and George J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21: 249-254
163. Wright P. E. and Dyson H. J. (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293: 321-331
164. Dunker A. K. and Obradovic Z. (2001) The protein trinity - linking function and disorder. Nat. Biotechnol. 19: 805-806
165. Uversky V. N. (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 11: 739-756
166. Dyson H. J. and Wright P. E. (2002) Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12: 54-60
167. Tompa P. (2002) Intrinsically unstructured proteins. Trends Biochem. Sci. 27: 527-533
168. Dunker A. K., Brown C. J., Lawson J. D., Iakoucheva L. M. and Obradovic Z. (2002) Intrinsic disorder and protein function. Biochemistry 41: 6573-6582
169. Dunker A. K., Brown C. J. and Obradovic Z. (2002) Identification and functions of usefully disordered proteins. Unfolded Proteins 62: 25-49
170. Iakoucheva L. M., Brown C. J., Lawson J. D., Obradovic Z. and Dunker A. K. (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323: 573-584
171. Uversky V. N. and Fink A. L. (2003) Conformational constraints for the amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta, in press
172. Glenner G. G. and Wong C. W. (1984) Alzheimers disease and Downs syndrome - sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122: 1131-1135
173. Masters C. L., Multhaup G., Simms G., Pottgiesser J., Martins R. N. and Beyreuther K. (1985) Neuronal origin of a cerebral amyloid - neurofibrillary tangles of Alzheimers disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4: 2757-2763
174. Lee V. M. Y., Balin B. J., Otvos L. and Trojanowski J. Q. (1991) A68 - a major subunit of pPaired helical filaments and derivatized forms of normal tau. Science 251: 675-678
175. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M. et al. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 11282-11286
176. Wisniewski K. E., Dalton A. J., Mclachlan D. R. C., Wen G. Y. and Wisniewski H. M. (1985) Alzheimers disease in Down syndrome - clinicopathologic studies. Neurology 35: 957-961
177. Arawaka S., Saito Y., Murayama S. and Mori H. (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclean. Neurology 51: 887-889
178. Arima K., Uéda K., Sunohara N., Hirai S., Izumiyama Y., Tonozuka-Uehara H. et al. (1998) Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res. 808: 93-100
179. Tu P. H., Galvin J. E., Baba M., Giasson B., Tomita T., Leight S. et al. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44: 415-422
180. Wakabayashi K., Yoshimoto M., Tsuji S. and Takahashi H. (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249: 180-182
181. Galvin J. E., Lee V. M., Schmidt M. L., Tu P. H., Iwatsubo T. and Trojanowski J. Q. (1999) Pathobiology of the Lewy body. Adv. Neurol. 80: 313-324
182. Uversky V. N. (2002) What does it mean to be natively unfolded? Eur. J. Biochem. 269: 2-12
183. Romero P., Obradovic Z., Kissinger C., Villafranca J. E. and Dunker A. K. (1997) Identifying disordered regions in proteins from amino acid sequence. Proc. IEEE Int. Conf. Neuronal Networks 1997 1: 90-95
184. Romero P., Obradovic Z. and Dunker A. K. (1998) Sequence data analysis for long distorted regions prediction in the calcineurin family. Genome Informatics 8: 110-124
185. Romero P., Obradovic Z., Kissinger C., Villafranca J. E., Garner E., Guilliot S. et al. (1998) Thousands of proteins likely to have long disordered regions. Pac. Symp. Biocomput. 3: 437-448
186. Romero P., Obradovic Z., Li X. H., Garner E. C., Brown C. J. and Dunker A. K. (2001) Sequence complexity of disordered protein. Proteins Structure Function and Genetics 42: 38-48
187. Dunker A. K., Obradovic Z., Romero P., Kissinger C. and Villafranca J. E. (1997) On the importance of being disordered. PDB Newsletter 81: 3-5
188. Dunker A. K., Garner E., Guilliot S., Romero P., Albercht K., Hart J. et al. (1998) Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac. Symp. Biocomput. 3: 473-484
189. Garner E., Guilliot S., Dunker A. K., Romero P. and Obradovic Z. (1998) Predicting long disordered regions in protein from amino acid sequence. Biophys. J. 74: A281
190. Li X., Romero P., Rani M., Dunker A. K. and Obradovic Z. (1999) Predicting Protein Disorder for N-, C- and Internal Regions. Genome Inform. Ser. Workshop Genome Inform. 10: 30-40
191. Li X., Obradovic Z., Brown C. J., Garner E. C. and Dunker A. K. (2000) Comparing predictors of disordered protein. Genome Inform. Ser. Workshop Genome Inform. 11: 172-184
192. Garner E., Cannon P., Romero P., Obradovic Z. and Dunker A. K. (1998) Predicting disordered regions from amino acid sequence: common themes despite differing structural characterization. Genome Inform. Ser. Workshop Genome Inform. 9: 201-213
193. Hemmings H. C. Jr, Nairn A. C., Aswad D. W. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus. J. Neurosci. 4: 99-110
194. Demarest S. J., Zhou S. Q., Robblee J., Fairman R., Chu B. and Raleigh D. P. (2001) A comparative study of peptide models of the alpha-domain of alpha-lactalbumin, lysozyme and alpha-lactalbumin/lysozyme chimeras allows the elucidation of critical factors that contribute to the ability to form stable partially folded states. Biochemistry 40: 2138-2147
195. Uversky V. N., Permyakov S. E., Zagranichny V. E., Rodionov I. L., Fink A. L., Cherskaya A. M. et al. (2002) Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: A natively unfolded protein. J. Proteome Res. 1: 149-159
196. Denning D. P., Uversky V., Patel S. S., Fink A. L. and Rexach M. (2002) The Saccharomyces cerevisiae nucleoporin Nup2p is a natively unfolded protein. J. Biol. Chem. 277: 33447-33455
197. Denning D. P., Patel S. S., Uversky V. N., Fink A. L. and Rexach M. (2003) Disorder in the pore. The FG nucleoporins of S. cerevisiae constitute a family of natively unfolded proteins. Proc. Natl. Acad. Sci. USA 100: 2450-2455
198. Adkins J. N. and Lumb K. J. (2002) Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins 46: 1-7
199. Uversky V. N., Li J., Souillac P., Millett I. S., Doniach S., Jakes R. et al. (2002) Biophysical properties of the synucleins and their propensities to fibrillate - inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J. Biol. Chem. 277: 11970-11978
200. Konno T., Tanaka N., Kataoka M., Takano E. and Maki M. (1997) A circular dichroism study of preferential hydration and alcohol effects on a denatured protein, pig calpastatin domain I. Biochim. Biophys. Acta 1342: 73-82
201. Dunker A. K., Brown C. J. and Obradovic Z. (2002) Identification and functions of usefully disordered proteins. Adv. Protein Chem. 62: 25-49
202. Plaxco K. W. and Gross M. (1997) Cell biology: the importance of being unfolded. Nature 386: 657-659
203. Schulz G. E. (1979) Nucleotide binding proteins. In: Molecular Mechanism of Biological Recognition, pp. 79-94, Elsevier/North-Holland Biomedical Press, New York
204. Pontius B. W. (1993) Close encounters - why unstructured, polymeric domains can increase rates of specific macromolecular association. Trends Biochem. Sci. 18: 181-186
205. Spolar R. S. and Record M. T. (1994) Coupling of local folding to site-specific binding of proteins to DNA. Science 263: 777-784
206. Rosenfeld R., Vajda S. and Delisi C. (1995) Flexible docking and design. Annu. Rev. Biophys Biomol. Struct. 24: 677-700
207. Namba K. (2001) Roles of partly unfolded conformations in macromolecular self-assembly. Genes Cells 6: 1-12
208. Uversky V. N. and Narizhneva N. V. (1998) Effect of natural ligands on the structural properties and conformational stability of proteins. Biochemistry 63: 420-433
209. Ben Zvi A. P. and Goloubinoff P. (2001) Review: mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones. J. Struct. Biol. 135: 84-93